Application
Antibody tested is caspase-2L (C-19): (A,B). Note cleavage of caspase-2L in lane B.Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human lymphoma tissue showing cytoplasmic staining.Application
Western blot analysis of caspase-2L (ICH-1L) precursor expression in Jurkat (A), HL-60 (B) and HuT 78 (C) whole cell lysates.Application
Western blot analysis of caspase-2L (Nedd-2) precursor expression in WEHI-3 whole cell lysate.| Product Name | caspase-2L Antibody (C-19) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | epitope mapping at the C-terminus of caspase-2L of mouse origin |
| Modification Notes | Caspase-2 (Nedd2, Ich-1) is an aspartate-specific cysteine protease that is activated in response to various apoptotic stimuli. Caspase-2 is unique among the caspases in that it has features of both upstream caspases (long prodomain) and downstream caspases (DEXD substrate specificity). Caspase-2 is highly expressed in the brain during development, and is expressed at low levels in adult tissue. Specifically, caspase-2 localizes to the mitochondria, the Golgi, the cytoplasm, and the nucleus. Caspase-2 exists as two isoforms, caspase-2L and caspase-2S, which are produced by alternative splicing and differ in their N and C-termini. Caspase-2L acts as a positive regulator of apoptosis, whereas caspase-2S functions as a negative regulator of apoptosis. Following apoptotic stimuli, the caspase-2L precursor undergoes cleavage at Asp-153 to produce a fragment p30. The p30 fragment undergoes further cleavage to generate a fragment containing amino acids 153-308 (p18) and a fragment containing amino acids 317-435 (p13 or p14). As apoptosis progresses, the p13 (p14) fragment can undergo further processing to yield a fragment containing amino acids 331-435 (p12). |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIPIFIHCELISA |
| recommended for detection of the p13 subunit, the p12 subunit, caspase-2L and the full length caspase-2 precursor of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA also reactive with additional species, including equine, canine and bovine: |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Alternative Names | epitope mapping at the C-terminus of caspase-2L of mouse origin |
|---|---|
| Tissue Specificity | epitope mapping at the C-terminus of caspase-2L of mouse origin |
| Entrez Gene | 835 |
|---|
Application
Antibody tested is caspase-2L (C-19): (A,B). Note cleavage of caspase-2L in lane B.
Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human lymphoma tissue showing cytoplasmic staining.
Application
Western blot analysis of caspase-2L (ICH-1L) precursor expression in Jurkat (A), HL-60 (B) and HuT 78 (C) whole cell lysates.
Application
Western blot analysis of caspase-2L (Nedd-2) precursor expression in WEHI-3 whole cell lysate.| Application Notes | recommended for detection of the p13 subunit, the p12 subunit, caspase-2L and the full length caspase-2 precursor of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA also reactive with additional species, including equine, canine and bovine: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
